Barclays’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-18
| Closed | -$4K | – | 5526 |
|
|
2020
Q2 | $4K | Sell |
18
-17
| -49% | -$4.02K | ﹤0.01% | 5408 |
|
|
2020
Q1 | $8K | Buy |
+35
| New | +$9.98K | ﹤0.01% | 5871 |
|
|
2019
Q4 | – | Sell |
-80
| Closed | -$24K | – | 6738 |
|
|
2019
Q3 | $24K | Hold |
80
| – | – | ﹤0.01% | 6170 |
|
|
2019
Q2 | $26K | Sell |
80
-76
| -49% | -$38.6K | ﹤0.01% | 6347 |
|
|
2019
Q1 | $98K | Sell |
156
-31
| -17% | -$14.1K | ﹤0.01% | 5376 |
|
|
2018
Q4 | $47K | Buy |
187
+72
| +63% | +$28.7K | ﹤0.01% | 5507 |
|
|
2018
Q3 | $53K | Buy |
115
+108
| +1,543% | +$52.3K | ﹤0.01% | 6048 |
|
|
2018
Q2 | $4K | Sell |
7
-139
| -95% | -$83.4K | ﹤0.01% | 6750 |
|
|
2018
Q1 | $84K | Sell |
146
-239
| -62% | -$151K | ﹤0.01% | 5506 |
|
|
2017
Q4 | $247K | Buy |
385
+173
| +82% | +$122K | ﹤0.01% | 4506 |
|
|
2017
Q3 | $199K | Buy |
212
+16
| +8% | +$12.2K | ﹤0.01% | 4433 |
|
|
2017
Q2 | $171K | Buy |
196
+95
| +94% | +$77.8K | ﹤0.01% | 4502 |
|
|
2017
Q1 | $69K | Sell |
101
-148
| -59% | -$97.5K | ﹤0.01% | 5148 |
|
|
2016
Q4 | $179K | Sell |
249
-13
| -5% | -$8.98K | ﹤0.01% | 4305 |
|
|
2016
Q3 | $193K | Buy |
262
+91
| +53% | +$73.7K | ﹤0.01% | 4000 |
|
|
2016
Q2 | $142K | Sell |
171
-48
| -22% | -$44.6K | ﹤0.01% | 4161 |
|
|
2016
Q1 | $169K | Buy |
219
+48
| +28% | +$37.7K | ﹤0.01% | 3956 |
|
|
2015
Q4 | $188K | Buy |
171
+143
| +511% | +$166K | ﹤0.01% | 3953 |
|
|
2015
Q3 | $22K | Sell |
28
-44
| -61% | -$63.8K | ﹤0.01% | 5418 |
|
|
2015
Q2 | $126K | Sell |
72
-497
| -87% | -$632K | ﹤0.01% | 4492 |
|
|
2015
Q1 | $626K | Buy |
569
+74
| +15% | +$86.7K | ﹤0.01% | 3383 |
|
|
2014
Q4 | $545K | Sell |
495
-19
| -4% | -$19.5K | ﹤0.01% | 3787 |
|
|
2014
Q3 | $509K | Sell |
514
-441
| -46% | -$498K | ﹤0.01% | 3936 |
|
|
2014
Q2 | $1.16M | Buy |
955
+257
| +37% | +$309K | ﹤0.01% | 3193 |
|
|
2014
Q1 | $922K | Buy |
698
+262
| +60% | +$341K | ﹤0.01% | 3332 |
|
|
2013
Q4 | $480K | Sell |
436
-263
| -38% | -$363K | ﹤0.01% | 4132 |
|
|
2013
Q3 | $846K | Buy |
699
+472
| +208% | +$320K | ﹤0.01% | 3538 |
|
|
2013
Q2 | $90K | Buy |
+227
| New | +$96.2K | ﹤0.01% | 5871 |
|
Other funds holding RMTI
AC
GC
Barclays's RMTI Position: Q2 2025 in Review
Barclays sold out of Rockwell Medical (RMTI) in Q2 2025, closing a stake of 125 shares — an estimated $1.42K sold.
Barclays first reported a position in RMTI in Q2 2013 and held it in 37 quarters. The position peaked at $1.08M in Q3 2013. 41 funds tracked by Wall St. Rank hold RMTI as of Q2 2025.
- Barclays reported no remaining Rockwell Medical position as of Q2 2025 after selling out during the quarter.
- Barclays sold 125 Rockwell Medical shares in Q2 2025, an estimated $1.42K.
- Barclays first reported a position in Rockwell Medical in Q2 2013 and held it in 37 quarters.
- Barclays's Rockwell Medical position peaked at $1.08M in Q3 2013.
- 41 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2025.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.